(PDF) Parkinson’s Disease, the Dopaminergic Neuron and

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate

Neurology and Therapy - United States

doi 10.1007/s40120-018-0091-2

Full Text

Abstract

Available in full text

Categories

Date

January 24, 2018

Authors

Mortimer Mamelak

Publisher

Springer Science and Business Media LLC

Related search

Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson’s Disease

Molecular Biology

English

Comparison of Human Primary With Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson’s Disease

Stem Cell Reviews and Reports

English

Dopaminergic Influences on Risk Preferences of Parkinson’s Disease Patients

Cognitive, Affective and Behavioral Neuroscience

Behavioral Neuroscience

Cognitive Neuroscience

English

miR-425 Deficiency Promotes Necroptosis and Dopaminergic Neurodegeneration in Parkinson’s Disease

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

SRC Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models

Frontiers in Neuroscience

English

The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease

Frontiers in Neurology

English

Dopaminergic and Clinical Correlates of Pathological Gambling in Parkinson’s Disease: A Case Report

Frontiers in Behavioral Neuroscience

Cognitive Neuroscience

Physiological Psychology

Behavioral Neuroscience

Neuropsychology

English

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models

Frontiers in Cellular Neuroscience

Molecular Neuroscience

English

Long-Term Efficacy and Safety With Continuous Dopaminergic Stimulation Pump Treatments in Parkinson’s Disease

European Neurological Review

English